LGND Long Call Strategy
LGND (Ligand Pharmaceuticals Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials.
LGND (Ligand Pharmaceuticals Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.43B, a trailing P/E of 28.64, a beta of 1.07 versus the broader market, a 52-week range of 98.89-247.38, average daily share volume of 227K, a public-listing history dating back to 1992, approximately 68 full-time employees. These structural characteristics shape how LGND stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.07 places LGND roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on LGND?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current LGND snapshot
As of May 15, 2026, spot at $215.00, ATM IV 39.40%, IV rank 17.92%, expected move 11.30%. The long call on LGND below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on LGND specifically: LGND IV at 39.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a LGND long call, with a market-implied 1-standard-deviation move of approximately 11.30% (roughly $24.29 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LGND expiries trade a higher absolute premium for lower per-day decay. Position sizing on LGND should anchor to the underlying notional of $215.00 per share and to the trader's directional view on LGND stock.
LGND long call setup
The LGND long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LGND near $215.00, the first option leg uses a $210.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LGND chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LGND shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $210.00 | $13.05 |
LGND long call risk and reward
- Net Premium / Debit
- -$1,305.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$1,305.00
- Breakeven(s)
- $223.05
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
LGND long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on LGND. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$1,305.00 |
| $47.55 | -77.9% | -$1,305.00 |
| $95.08 | -55.8% | -$1,305.00 |
| $142.62 | -33.7% | -$1,305.00 |
| $190.16 | -11.6% | -$1,305.00 |
| $237.69 | +10.6% | +$1,464.29 |
| $285.23 | +32.7% | +$6,217.95 |
| $332.77 | +54.8% | +$10,971.61 |
| $380.30 | +76.9% | +$15,725.27 |
| $427.84 | +99.0% | +$20,478.92 |
When traders use long call on LGND
Long calls on LGND express a bullish thesis with defined risk; traders use them ahead of LGND catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
LGND thesis for this long call
The market-implied 1-standard-deviation range for LGND extends from approximately $190.71 on the downside to $239.29 on the upside. A LGND long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current LGND IV rank near 17.92% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LGND at 39.40%. As a Healthcare name, LGND options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LGND-specific events.
LGND long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LGND positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LGND alongside the broader basket even when LGND-specific fundamentals are unchanged. Long-premium structures like a long call on LGND are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current LGND chain quotes before placing a trade.
Frequently asked questions
- What is a long call on LGND?
- A long call on LGND is the long call strategy applied to LGND (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With LGND stock trading near $215.00, the strikes shown on this page are snapped to the nearest listed LGND chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LGND long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the LGND long call priced from the end-of-day chain at a 30-day expiry (ATM IV 39.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,305.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LGND long call?
- The breakeven for the LGND long call priced on this page is roughly $223.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LGND market-implied 1-standard-deviation expected move is approximately 11.30%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on LGND?
- Long calls on LGND express a bullish thesis with defined risk; traders use them ahead of LGND catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current LGND implied volatility affect this long call?
- LGND ATM IV is at 39.40% with IV rank near 17.92%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.